Looking at liver problems in adults with Turner syndrome
Studies how often liver changes occur in adult women with Turner syndrome.
Key facts
- Who runs it
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Where
- Italy1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Characterization of Hepatopathy in Turner Syndrome: Analysis of Determinants
- Status
- Recruiting
- People taking part
- 120 people, planned
- Started
- 7 Jan 2025
- Planned end
- 7 Jan 2026
- Type of study
- Observational
- Record updated
- 27 January 2025
Who can take part
The trial is looking for adult women with Turner syndrome. It studies how often liver changes happen in blood tests and scans.
- Age
- 18 years or older
- Sex
- Female
- Disease stage
- Turner syndrome confirmed by a chromosome test (karyotype) on a blood sample.
- Earlier treatment
- People taking drugs that cause large changes in liver enzymes cannot join.
- Biomarker or test result
- Turner syndrome shown by karyotype analysis on peripheral blood.
- Main reasons for not taking part
- Taking drugs that cause significant changes in liver enzyme levels (liver function alteration, LFA)
Show the full registry criteria (4)Hide the full registry criteria
Who can take part
- Diagnosis of Turner syndrome made by karyotype analysis on peripheral blood
- Age 18 years or older
- Written informed consent obtained
Who cannot take part
- TS patients on therapy with drugs responsible for significant liver enzyme alterations (liver function alteration, LFA)
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Sex
- Turner syndrome
This trial is currently available in Italy.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The present study is therefore aimed at investigating the prevalence of hepatic alterations (laboratory and imaging) in adult patients with TS and generating hypothesissto the possible etiopathogenetic factors most involved, as well as evaluating the correlation between biochemical and structural abnormalities.
Read full original descriptionShow less
Thus, the study could provide relevant etiopathogenetic and prognostic results on the development of hepatopathy in TS patients.
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 3 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Characterization of Hepatopathy in Turner Syndrome: Analysis of Determinants in an Observational Study
- Plain-language title
- Looking at liver problems in adults with Turner syndromeGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Criteria questions
- Built from NCT06794190, who can take part
- Record updated
- 27 January 2025